JP5265915B2 - プロテアソームを阻害するための（−）−エピガロカテキンガラート誘導体 - Google Patents

プロテアソームを阻害するための（−）−エピガロカテキンガラート誘導体 Download PDF

Info

Publication number
JP5265915B2
JP5265915B2 JP2007526180A JP2007526180A JP5265915B2 JP 5265915 B2 JP5265915 B2 JP 5265915B2 JP 2007526180 A JP2007526180 A JP 2007526180A JP 2007526180 A JP2007526180 A JP 2007526180A JP 5265915 B2 JP5265915 B2 JP 5265915B2
Authority
JP
Japan
Prior art keywords
group
acetate
cells
egcg
proteasome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007526180A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509939A5 (https=
JP2008509939A (ja
Inventor
チャン，タク−ハン
ラム，ワイ−ハー
チョウ，ラリー・ミン−チュン
ドゥ，キン・ピン
クーン，デボラ・ジョイス
カジ，アスラムザマン
ワン，シェン・ビャオ
ランディス−ピウォワー，クリスティン・アール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hong Kong Polytechnic University HKPU
Original Assignee
Hong Kong Polytechnic University HKPU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/921,332 external-priority patent/US7544816B2/en
Application filed by Hong Kong Polytechnic University HKPU filed Critical Hong Kong Polytechnic University HKPU
Publication of JP2008509939A publication Critical patent/JP2008509939A/ja
Publication of JP2008509939A5 publication Critical patent/JP2008509939A5/ja
Application granted granted Critical
Publication of JP5265915B2 publication Critical patent/JP5265915B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
JP2007526180A 2004-08-19 2005-08-15 プロテアソームを阻害するための（−）−エピガロカテキンガラート誘導体 Expired - Fee Related JP5265915B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/921,332 US7544816B2 (en) 2004-08-19 2004-08-19 (−)-Epigallocatechin gallate derivatives for inhibiting proteasome
US10/921,332 2004-08-19
US64956905P 2005-02-04 2005-02-04
US60/649,569 2005-02-04
PCT/CN2005/001262 WO2006017981A1 (en) 2004-08-19 2005-08-15 (-)-epigallocatechin gallate derivatives for inhibiting proteasome

Publications (3)

Publication Number Publication Date
JP2008509939A JP2008509939A (ja) 2008-04-03
JP2008509939A5 JP2008509939A5 (https=) 2008-10-02
JP5265915B2 true JP5265915B2 (ja) 2013-08-14

Family

ID=35907224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007526180A Expired - Fee Related JP5265915B2 (ja) 2004-08-19 2005-08-15 プロテアソームを阻害するための（−）−エピガロカテキンガラート誘導体

Country Status (6)

Country Link
US (4) US8193377B2 (https=)
EP (1) EP1778663B1 (https=)
JP (1) JP5265915B2 (https=)
CN (1) CN101072764B (https=)
ES (1) ES2660339T3 (https=)
WO (1) WO2006017981A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1778663B1 (en) 2004-08-19 2017-12-13 The Hong Kong Polytechnic University (-)-epigallocatechin gallate derivatives for inhibiting proteasome
EP2088205A1 (en) 2008-02-11 2009-08-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) PSMB10: A diagnosis marker and therapeutic target of chronic rejection.
US8784873B2 (en) * 2009-07-22 2014-07-22 Naturewise Biotech & Medicals Corporation Use of histone deacetylase inhibitors in changing MRJP3 protein in royal jelly
US9126997B1 (en) 2010-09-07 2015-09-08 Northwestern University Synergistic effect of glucocorticoid receptor agonists in combination with proteosome inhibitors for treating leukemia and myeloma
GB2500136B (en) 2010-10-15 2015-02-18 Microsoft Corp Parasitic folded loop antenna
CN102078316A (zh) * 2011-01-24 2011-06-01 广西医科大学 表没食子儿茶素没食子酸酯衍生物在抗肿瘤药物中的应用
CN102153535A (zh) * 2011-03-04 2011-08-17 中国海洋大学 一种抗肿瘤多药耐药抑制剂苯并吡喃-3-醇酯化衍生物及其制备方法和应用
EP2557079A1 (en) * 2011-08-09 2013-02-13 Nestec S.A. Synthesis of catechin and epicatechin conjugates
WO2017132775A1 (en) * 2016-02-05 2017-08-10 Viteava Pharmaceuticals Inc. Novel compositions and methods for the treatment of leiomyoma
CN108129438A (zh) * 2017-12-25 2018-06-08 中国海洋大学 一种含2-苯色满母核的化合物及其制备方法
KR102057773B1 (ko) 2018-03-30 2019-12-19 건국대학교 산학협력단 에피갈로카테킨 갈레이트 유도체를 포함하는 유방암 예방 또는 치료용 약학적 조성물
JP2021527048A (ja) * 2018-06-05 2021-10-11 フラッグシップ パイオニアリング イノベーションズ ブイ， インコーポレイテッド 癌治療のためのアシル化カテキンポリフェノールおよびその使用方法
CN116162078B (zh) * 2022-12-27 2024-10-29 佛山病原微生物研究院 一种表没食子儿茶素没食子酸酯类化合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57118580A (en) * 1981-01-16 1982-07-23 Kanebo Ltd Novel catechin derivative
JPS57120584A (en) * 1981-01-20 1982-07-27 Kanebo Ltd Production of catechin derivative
JPH10254087A (ja) * 1997-03-14 1998-09-25 Konica Corp ハロゲン化銀写真感光材料
US6696484B2 (en) * 1997-10-31 2004-02-24 University Of Chicago Office Of Technology And Intellectual Property Method and compositions for regulation of 5-alpha reductase activity
US6576660B1 (en) * 1997-10-31 2003-06-10 Arch Development Corporation Methods and compositions for regulation of 5-α-reductase activity
US7122573B2 (en) * 2002-12-06 2006-10-17 Sri International Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents
US7544816B2 (en) * 2004-08-19 2009-06-09 The Hong Kong Polytechnic University (−)-Epigallocatechin gallate derivatives for inhibiting proteasome
EP1778663B1 (en) * 2004-08-19 2017-12-13 The Hong Kong Polytechnic University (-)-epigallocatechin gallate derivatives for inhibiting proteasome

Also Published As

Publication number Publication date
US9169230B2 (en) 2015-10-27
JP2008509939A (ja) 2008-04-03
US8193377B2 (en) 2012-06-05
CN101072764A (zh) 2007-11-14
US20080176931A1 (en) 2008-07-24
WO2006017981A9 (en) 2006-05-11
WO2006017981A1 (en) 2006-02-23
CN101072764B (zh) 2013-07-10
EP1778663A4 (en) 2008-08-06
US20160068503A1 (en) 2016-03-10
ES2660339T3 (es) 2018-03-21
US20140213802A1 (en) 2014-07-31
EP1778663A1 (en) 2007-05-02
US8710248B2 (en) 2014-04-29
US20120232135A1 (en) 2012-09-13
EP1778663B1 (en) 2017-12-13

Similar Documents

Publication Publication Date Title
US8710248B2 (en) (−)-epigallocatechin gallate derivatives for inhibiting proteasome
Jeon et al. Green tea catechins as a BACE1 (β-secretase) inhibitor
AU2009200907A1 (en) Isolation, purification and synthesis of procyanidin B2 and uses thereof
US7544816B2 (en) (−)-Epigallocatechin gallate derivatives for inhibiting proteasome
WO2006093547A2 (en) Novel lipoxygenase inhibitors
EP2721000A1 (en) Synthetic epigallocatechin gallate (egcg) analogs
JP2796876B2 (ja) 置換ピロリジン化合物および医薬組成物
Macedo et al. Anti-inflammatory effects of naringenin 8-sulphonate from Parinari excelsa Sabine stem bark and its semi-synthetic derivatives
SK50062012A3 (sk) Quercetin derivatives, pharmaceutical compositions comprising them and their use
US9526706B1 (en) Method of using dihydro-resveratrol for treating acute pancreatitis and associated pulmonary injury
AU2009211300A1 (en) Phenyl-prenyl derivatives, of marine and synthetic origin, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
Kim et al. α-Phenyl-N-tert-butyl nitrone (PBN) derivatives: synthesis and protective action against microvascular damages induced by ischemia/reperfusion
Chan et al. inhibiting proteasome
JP3248183B2 (ja) 新規な心臓保護剤
US20090047221A1 (en) Compounds and compositions useful in the treatment of neoplasia
AU2004257887A1 (en) Chemical compounds containing tocopherol and at least one additional pharmaceutical active substance
EP3733658B1 (en) Prenylated benzopyranes as ppar agonists
Chen et al. Design, Synthesis, and Biological Evaluation of Novel Tetramethylpyrazine-nitrone Derivatives as Antioxidants
Huo et al. Structural modification and biological evaluation of spirolactone type ent-kauranoid isodonal as potential anti-melanoma agents
Yasuda et al. Preparation and antioxidant/pro-oxidant activities of 3-monosubstituted 5-hydroxyoxindole derivatives
TWI396533B (zh) 異戊二烯類黃酮化合物及其用途
Jaiswal et al. Synthesis and evaluation of novel heterocyclic chromene derivatives as antimicrobial and antioxidant agents
Castrillón López et al. Synthesis and in-vitro Evaluation of S-allyl Cysteine Ester-Caffeic Acid Amide Hybrids as Potential Anticancer Agents

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080812

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080812

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20110912

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120125

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120424

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120502

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120514

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120808

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121122

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20130227

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130404

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130502

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5265915

Country of ref document: JP

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees